Bausch Health Companies Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated February 18, 2026, reports the results of operations and financial condition for Bausch Health Companies Inc. The filing covers the quarter and the full year ended December 31, 2025. The company is incorporated in British Columbia, Canada, and its common shares trade on the New York Stock Exchange and Toronto Stock Exchange under the symbol BHC.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
The filing does not explicitly list material changes versus prior periods within the text provided. It serves as a notification that the company has issued a press release containing this comparative data for the fourth quarter and year ended December 31, 2025.
Guidance, Outlook, and Risks
The document does not contain specific guidance, outlook, management commentary, or risk factors. It includes a standard disclaimer stating that the report and the attached press release do not constitute an offer to sell securities and are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2025.
- Verify year-over-year growth rates and margin trends detailed in the attached press release.
- Check for any updated forward-looking guidance or strategic initiatives mentioned in the press release.
- Confirm the status of debt obligations and liquidity positions as of December 31, 2025, in the full financial statements referenced.